RTX (RTX) Q4 24/25 earnings summary

Executive summary

• Regained profitable growth with total revenue up 10% year-over-year to DKK 547 million, driven by strong performance in Enterprise (up 21%) and Healthcare (up 43%) segments.

• Focused execution and operational efficiency led to a 3.3 percentage point increase in gross margin to 50% and reduced inventory to DKK 37 million.

• Strengthened liquidity with a year-end net liquidity position of DKK 153 million.

• Leadership transition completed with a new CEO appointed in March 2025.

• Sustainability efforts advanced with completion of Scope 3 emissions mapping.

Financial highlights

• Revenue for 2024/25 rose 10% year-over-year to DKK 547 million; adjusted for USD effects, growth was 12%.

• Gross margin increased to 50% from 46.7% the previous year, driven by product/customer mix and cost optimization.

• EBITDA for the year was DKK 35.5 million, up from DKK 3.1 million in 2023/24.

• Inventory reduced to DKK 37 million, and free cash flow improved to DKK 52.8 million.

• Net liquidity at year-end was DKK 153 million, up from DKK 107 million.

Outlook and guidance

• FY 2025/26 revenue guidance: DKK 575–625 million.

• EBITDA expected between DKK 35–65 million; EBIT between DKK 0–30 million.

• Growth outlook supported by a strong pipeline, customer relationships, and new product launches.

• Key risks include macroeconomic volatility and USD exchange rate fluctuations.